Labiotech.eu

How to navigate the biotech funding landscape? 🚣 Funding a startup is challenging, and it can be even trickier in the biotech industry. While it seems that biotech funding is in recovery, venture capital (VC) investment is still cautious and tends to go for de-risk opportunities. 💸 It is a good thing that’s not the only option for startups! While VC remains essential startups need to rely on multiple sources throughout their journey: grants, corporate venture capital, partnerships, debt financing…  We reached out to experts to see clearer in this sometimes opaque environment. 🧭 Find out what they told us in our latest article! ⬇️ https://lnkd.in/dtWt6vTH #biotechfunding #startupchallenges #venturecapital #biotechstartups #grants #partnerships #biotechindustry #healthcareinnovation #startupfunding Kathleen Lee | Greater Phoenix Economic Council | Jörg Klumbis | Peptomyc | Katerina Stroponiati | Brilliant Minds | Michael Salako PhD MBA | Start Codon | Abveris | AngelList | Life Science Angels | TCA Venture Group

What’s up with the recent radiotherapeutics boom? 💥 Radiopharmaceuticals have been a hot topic of late. These drugs can diagnose as well as treat diseases. 💉 🎙️ Labiotech has been in conversation with radiopharmaceuticals expert Ken Herrmann, Molecular Partners’ CEO Patrick Amstutz, and SVP of R&D Daniel Steiner, about the challenges facing radiopharma and how they’re being addressed. Molecular Partners’ radioligand therapy is being investigated to treat small-cell lung carcinoma, a highly aggressive form of lung cancer. 🫁 🎧 Tune into the latest episode of the Beyond Biotech Podcast to find out more! 👇 https://lnkd.in/dpHzDjJf #BeyondBiotechPodcast #radiotherapeutics #radiopharmaceuticals #cancertreatment #medicalinnovation #healthcaretrends #biotechnews 

💰 Biotech's Top Investments This Week! 🚀 🇺🇸 Formation Bio | $372 million series D | AI-based drug development | phase 2 in atopic dermatitis 🇺🇸 Alumis | $250 million initial public offering | precision medicine | phase 2 in psoriasis   🇺🇸 Cartesian Therapeutics | $130 million PIPE | cell therapies | phase 2 in myasthenia gravis 🇺🇸 🇬🇧 Eliem Therapeutics | $120 million PIPE | antibodies | phase 1 in systemic lupus erythematosus 🇺🇸 Savara Inc. | $100 million offering | rare respiratory disease therapies | phase 3 in autoimmune pulmonary alveolar proteinosis 🇺🇸 Vigil Neuroscience | $40 million investment | neurodegenerative disease therapies | phase 2 in adult-onset leukoencephalopathy 🇺🇸 NEONC Technologies | $18.5 million financing | central nervous system therapeutics | phase 2 in brain cancer 🇺🇸 Holoclara Inc | $16 million series A | worm-derived therapies | preclinical in allergic and autoimmune diseases 🇺🇸 Checkpoint Therapeutics Inc | $12 million registered direct offering | immunotherapy | phase 3 in cutaneous squamous cell carcinoma completed 🇬🇧 Mission Therapeutics | $5.2 million grant | small molecules | phase 2 in heart failure 🇺🇸 Eyenovia, Inc.| $5m registered direct offering | eyecare | phase 3 in pediatric myopia 🇺🇸 Tiziana Life Sciences | $3.4 million financing | neurodegenerative disease therapies | phase 2 in multiple sclerosis Subscribe to our newsletter for more fundraising updates! 🔗 https://lnkd.in/dsgz62YY #fundraising #funding #biotech #venturecapital #fundinground #biotechstartup #seriesa #seriesb #seriesc #investors #IPO #seedfunding

What treatments are in store for Parkinson’s disease? 🔍 Parkinson’s disease is a condition that can impair motor function and affects about 10 million people around the world. 🧠 While no cure has been developed yet, growing research aims to broaden therapeutic options for patients with the neurodegenerative disease. 🏥 From Gain Therapeutics’ preclinical results and Cerevel Therapeutics’s phase 3 drug to GLP-1 agonists and gene therapies, there’s quite a bit going on to tackle Parkinson’s symptoms. 🧬 Read our latest article to find out more about recent developments in Parkinson’s research! 👇 https://lnkd.in/dEyW69_V AbbVie | Asklepios BioPharmaceutical, Inc. (AskBio) | Bayer | University of Bergen/Haukeland University Hospital | Parkinson's UK | Parkinson's Foundation | The Michael J. Fox Foundation for Parkinson's Research #Biotech #Biopharma #Research #Innovation #Parkinsons #ParkinsonsDisease #Neurodegenerative #Parkinson

It’s time to find out who bagged the biggest private biotech investments in June 2024! 💰 The biggest funding rounds went to the companies Formation Bio, ITM Isotope Technologies Munich SE, and Marea Therapeutics. 📈 Meanwhile, around the world, oncology and central nervous system players attracted the biggest funding rounds overall. 🌍 Read our latest article to find out more about biotech’s biggest private investments in June, as we break down the investments by location and funding type, and compare June’s fundraising to previous months. 💡 https://lnkd.in/dYvuBVt9 #biotechinvestments #oncologyresearch #biotechfunding #healthcareinnovation #investmenttrends #globalbiotech #lifesciences Santa Ana Bio, Inc. | Alzheon, Inc. | Preserving Future Memories | Bright Peak Therapeutics | iOnctura | InduPro | Exsilio Therapeutics | Elion Therapeutics | Enveda Biosciences | Iambic Therapeutics | Spur Therapeutics | āshibio, Inc | Adcytherix | Envisagenics | Vilya | Frontier Medicines | Augustine Therapeutics | GPN Vaccines

Take a look at these 18 Swiss biotech companies to keep an eye on.

How is biotech pioneering new patient options for endometriosis? 🚀 Affecting around 190 million women and girls, endometriosis is a condition that has been rather difficult to treat with no cures to date. 📅 It is caused by the growth of tissue outside the uterus, leading to debilitating pelvic pain during sex and heavy periods. With some clinical trials showing promise and with the discovery of new drug targets, there is hope for better endometriosis care. 💊 Read our latest article to find out about some of the recent advancements in endometriosis research! 👇 https://lnkd.in/dXAXCu7w #endometriosis #biotechinnovation #womenshealth #clinicaltrials #medicalresearch #healthcareinnovation #biotechnews Bruce Nicholson | Hera Biotech | The University of Edinburgh | TiumBio | Serac Healthcare | Western Sydney University | FimmCyte | Celmatix

What are the challenges in cell and gene therapy (CGT) development? 🔎 A significant challenge in CGT development is the lack of adequate infrastructure for temperature-controlled storage. Only a small percentage of studies require ultra-low temperature storage, making many researchers hesitant to engage in CGT research. Additionally, maintaining a closed-loop supply chain is critical for CGT. 🌡️ Cryoport Systems addresses this by offering advanced storage facilities and expertise, ensuring the integrity and compliance of stored materials. ❄️ Find out more below! ⬇️ https://lnkd.in/dUeDS9XG #biopharma #healthcareinnovation #advancedtherapies #medicalresearch #biotechindustry #pharmalogistics #coldchainlogistics #biotechnews #therapeuticdevelopment

Switzerland isn’t just mountains and lakes, it’s also biotech! ⛰️ Last year Swiss biotech raised over $2 billion with both public and private companies contributing. Noema Pharma and Alentis Therapeutics completed the most notable financing rounds, each securing over $100 million. 💸 With companies contributing to cancer research, gene and cell therapy, and also the biology of aging, Switzerland’s biotech ecosystem is very mature. 🧑🔬 In this article, we focus on 18 biotechs based in Switzerland! ⬇️ https://lnkd.in/d_YZ2_xz #Swissbiotech #biotechinnovation #biotechfunding #genetherapy #celltherapy #biotechecosystem #biotechstartups Araris Biotech AG | CDR-Life Inc. | CUTISS AG | Endogena Therapeutics, Inc. | Engimmune Therapeutics | FoRx Therapeutics | GlycoEra AG | HAYA Therapeutics | ImmunOs Therapeutics AG | iOnctura | MUVON Therapeutics AG | NewBiologix | Nouscom | STALICLA | Synendos Therapeutics AG | TOLREMO therapeutics | Swiss Biotech Association | Switzerland Global Enterprise | Innosuisse | Biopôle Lausanne | Basel Area Business & Innovation | BioAlps - Swiss Health Valley | Swiss Personalized Health Network (SPHN)

Did you know that biotechnology can actually have an impact on sports performance? 🏃♂️ From genetic profiling, stem cells, and wearable technologies, biotech can be used to improve both athletic performance and injury recovery in sports. 📈 However, the field also brings with it the potential issue of ‘gene doping’ to illegally enhance performance. 🚫 As the 2024 Olympic Games are fast approaching, read our latest article as we take a look at how biotech is impacting sports performance worldwide! 👇️ https://lnkd.in/dGtVdTSJ #sportsperformance #biotech #geneticprofiling #athleticperformance #OlympicGames2024 #biotechinsports #sportsinnovation #biotechnews